State IN
Clinical Trials in Indiana
Indiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Indiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Indiana
Breast Cancer (4)Non-Small Cell Lung Cancer (3)Prostate Cancer (3)Head and Neck Squamous Cell Carcinoma (2)Pancreatic Cancer (2)Triple Negative Breast Cancer (2)Sickle Cell Disease (2)Ovarian Cancer (2)Endometrial Cancer (2)Pancreatic Ductal Adenocarcinoma (2)Primary Immune Deficiency Disorder (2)Respiratory Distress Syndrome (2)
Frequently Asked Questions — Clinical Trials in Indiana
How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 174 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 174. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Non-Small Cell Lung Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Indiana
NCT07000084 Phase 3
Recruiting
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BC...
Condition
Recurrent Non-Muscle Invasive Bladder Carcinoma
Enrollment
330 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06683092 N/A
Recruiting
Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Condition
Cystic Fibrosis
Enrollment
200 pts
Location
United States
Sponsor
Boston Children's Hospital
NCT07227532 N/A
Recruiting
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of ...
Condition
Atrial Fibrillation
Enrollment
276 pts
Location
United States
Sponsor
Biosense Webster, Inc.
NCT06577441 Phase 2
Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedaz...
Condition
Myelodysplastic Syndrome
Enrollment
54 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT02432092 N/A
Recruiting
Pediatric Cardiomyopathy Mutation Analysis
Condition
Cardiomyopathies
Enrollment
300 pts
Location
United States
Sponsor
Indiana University
NCT07011719 Phase 3
Recruiting
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients...
Condition
Metastatic Clear Cell Renal Cell Carcinoma
Enrollment
720 pts
Location
United States, Australia, Canada
Sponsor
Arcus Biosciences, Inc.
NCT03911700 N/A
Recruiting
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Condition
Open Midline Laparotomy
Enrollment
477 pts
Location
United States, Austria, Belgium
Sponsor
C. R. Bard
NCT06832280 N/A
Recruiting
Improving Parental Support in Hypospadias Care
Condition
Hypospadias
Enrollment
324 pts
Location
United States
Sponsor
University of North Carolina,
NCT06318169 Phase 3
Recruiting
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With ...
Condition
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
Enrollment
1,350 pts
Location
United States, Argentina, Australia
Sponsor
89bio, Inc.
NCT07174583 Phase 1, Phase 2
Recruiting
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell L...
Condition
Small-cell Lung Cancer
Enrollment
208 pts
Location
United States, Australia, Brazil
Sponsor
IDEAYA Biosciences
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT07356323 N/A
Recruiting
A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an ...
Condition
Arthroplasty Replacement, Knee
Enrollment
179 pts
Location
United States
Sponsor
Solventum US LLC
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT07405983 N/A
Recruiting
TOUCH® CMC 1 New Enrollment US Study
Condition
Osteoarthritis Thumb
Enrollment
163 pts
Location
United States
Sponsor
Keri Medical SA
NCT04972942 Phase 1
Recruiting
Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in C...
Condition
T-cell Acute Lymphoblastic Leukemia
Enrollment
30 pts
Location
United States
Sponsor
New York Medical College
NCT05671510 Phase 3
Recruiting
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhib...
Condition
Non Small Cell Lung Cancer
Enrollment
630 pts
Location
United States, Australia, Belgium
Sponsor
OncoC4, Inc.
NCT06988618 N/A
Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Seve...
Condition
Prurigo Nodularis
Enrollment
600 pts
Location
United States, Germany
Sponsor
Galderma R&D
NCT05912517 Phase 3
Recruiting
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of th...
Condition
Hemolytic Disease of the Fetus and Newborn
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT06681220 Phase 1, Phase 2
Recruiting
Biomarker Directed Trial of Temozolomide and Stenoparib in Relapsed SCLC
Condition
Relapsed Small Cell Lung Cancer
Enrollment
166 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT07288827 N/A
Recruiting
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
Condition
Primary Ciliary Dyskinesia
Enrollment
40 pts
Location
United States
Sponsor
Indiana University
NCT03266627 Phase 2
Recruiting
Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
Condition
Adenovirus
Enrollment
20 pts
Location
United States
Sponsor
New York Medical College
NCT05108090 N/A
Recruiting
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and...
Condition
Squamous Cell Carcinoma
Enrollment
94 pts
Location
United States
Sponsor
Indiana University
NCT02932150 Phase 2
Recruiting
Study of Tenofovir Alafenamide (TAF) in Children and Teen Participants With Chro...
Condition
Chronic Hepatitis B
Enrollment
150 pts
Location
United States, Belgium, Canada
Sponsor
Gilead Sciences
NCT06250309 N/A
Recruiting
Mediterranean Diet Versus Western Diet on Fatigue in Autoimmune Hepatitis Patien...
Condition
Autoimmune Hepatitis
Enrollment
48 pts
Location
United States
Sponsor
Indiana University
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology